Recent news on Taxotere

Oral and IV Hycamtin® Equally Effective for Small Cell Lung Cancer  -  25 May 2007
Cancer Consultants (press release),However, Taxotere is administered intravenously, which requires extended stays at medical facilities for administration as well as potential for pain and

Provenge Followed by Taxotere May Improve Survival in Metastatic ...  -  May 23, 2007
Cancer Consultants (press release),The current presentation evaluated survival in a subgroup of 82 patients who received Taxotere for disease progression after Provenge or Placebo.

Neoadjuvant Taxotere®, Navelbine®, and Herceptin® Active for ...  -  May 3, 2007
Cancer Consultants (press release),According to the results of a Phase II clinical trial published in the Journal of Clinical Oncology, neoadjuvant (before surgery) treatment with Taxotere®

Point Thera puts talabostat trial on hold  -  May 21, 2007
MarketWatchIn one of the trials, which used talabostat in combination with the leading cancer drug Taxotere, patients appeared to have a lower survival rate than those

ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic ...  -  Apr 25, 2007
PipelineReview.com (press release),In this study, docetaxel concentration in plasma was sequentially measured over 24 hours following intravenous injections with either ANX-514 or Taxotere.

Additional Efficacy Data from Satraplatin SPARC Phase 3 ...  -  May 21, 2007
PR Newswire (press release),Pain response rates for patients treated with prior Taxotere were 25.7 percent for the satraplatin arm compared with 13.1 percent for control (p<0.015).

Dendreon shares plummet as FDA delays prostate cancer drug  -  May 9, 2007
Seattle Times,The last drug approved by the FDA to prolong survival in prostate cancer was Taxotere, a chemotherapy drug from Paris- based Sanofi-Aventis SA.

Drug body backs dual head and neck cancer treatment  -  May 7, 2007
The Herald,Taxotere, used to treat sufferers from the aggressive cancer, has been recommended for use by the Scottish Medicines Consortium (SMC).

Additional Satraplatin Efficacy Data From Phase 3 SPARC Trial ...  -  May 21, 2007
PR Newswire (press release),These results were consistent across subsets, including patients treated with prior Taxotere(R) (docetaxel). All pain progression events were adjudicated by

New drug hope for head and neck cancer sufferers  -  May 7, 2007
Scotsman,Taxotere, used to treat the aggressive cancer, has been recommended for use by the Scottish Medicines Consortium. Trials found patients taking the drug

NEW HOPE FOR CANCER PATIENTS  -  May 7, 2007
Glasgow Daily Record,The Scottish Medicines Consortium have given the green light to the chemotherapy drug Taxotere. In tests, patients who took it had a 30 per cent lower risk

New cancer drug breakthrough  -  May 7, 2007
Midlothian Today,Taxotere, used to treat sufferers of the aggressive cancer, has been recommended for use by the Scottish Medicines Consortium (SMC).

Poniard To Presents Data From Picoplatin Phase 2 Small Cell Lung ...  -  May 23, 2007
eMaxHealth.com,...an ongoing Phase 1/2 study of picoplatin and docetaxel (Taxotere(R)) in chemotherapy-naive patients with metastatic hormone-refractory prostate cancer.

Point Therapeutics Announces Interim Analysis to be Performed on ...  -  May 15, 2007
PharmaLive.com (press release),The Company may also perform an unscheduled interim analysis on its Phase 3 study evaluating talabostat in combination with docetaxal (Taxotere(R)

Lung Cancer is the Third Most Common Malignant Disease and the ...  -  May 13, 2007
Fuerteventura Digital,Chemotherapy drugs will experience generic erosion and three major chemotherapy drugs go off patent before 2012; Aventis’ Taxotere (docetaxel),

Lung Cancer is the Third Most Common Malignant Disease and the ...  -  May 11, 2007
PharmaLive.com (press release),Chemotherapy drugs will experience generic erosion and three major chemotherapy drugs go off patent before 2012; Aventis' Taxotere (docetaxel),

Cell Genesys Reports First Quarter 2007 Results  -  May 10, 2007
PR Newswire (press release),...survival of 18.9 months for metastatic hormone-refractory prostate cancer patients treated with Taxotere(R) (docetaxel) chemotherapy plus prednisone,

ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic ...  -  26 Apr 2007
PipelineReview.com (press release),In this study, docetaxel concentration in plasma was sequentially measured over 24 hours following intravenous injections with either ANX-514 or Taxotere.

Neoadjuvant Taxotere®, Navelbine® and Herceptin® Active for ...  -  Apr 4, 2007
Cancer Consultants (press release),Researchers involved in a multicenter trial have reported that a regimen of Taxotere (docetaxel), Navelbine (venorelbine) and Herceptin® produces a 39%

Analysis: Sanofi's Taxotere keeps top spot  -  Mar 27, 2007
United Press InternationalWASHINGTON, March 27 (UPI) -- Sanofi-Aventis's cancer drug Taxotere will remain the market leader through 2015, but generic erosion will significantly cut

Sanofi-Aventis's Taxotere Will Lead the Taxane Market Through 2010 ...  -  Mar 27, 2007
PR Newswire (press release),The new Pharmacor report Taxanes finds that the increasing use of Taxotere in chemotherapy treatment for prostate cancer and non-small-cell lung cancer and

Enhancing chemotherapy's efficacy: new agent has synergistic ...  -  Apr 17, 2007
innovations report,Several widely used drugs, including paclitaxel (Taxol), docetaxel (Taxotere) and long-time standby vincristine, take the latter approach,

Amantadine adds fallible human the nursing stairs.  -  Apr 19, 2007
Journal lycéen,Measures to official records Taxotere nurses quit Pentoxifylline to answer paradigm. The sensitivity or in Hydroxyurea incurs expenses Bacitracin has taken

Dendreon Corporation: The Next Biotech Winner  -  Apr 4, 2007
Seeking Alpha,Competition: Taxotere, a very strong chemotherapy drug, is the only drug approved by the FDA for AIPC that has a proven survival benefit.

Cell Genesys: GVAX shows broad response  -  Apr 17, 2007
BusinessWeek18.9 months for prostate cancer patients given the current standard treatment, Sanofi Aventis SA's Taxotere chemotherapy along with the steroid prednisone.

Hybrigenics' Inecalcitol Shows High Level Of Tolerance  -  Apr 17, 2007
Medical News Today (press release),Calcitriol is currently in Phase III clinical trial for hormone-refractory prostate cancer in combination with Taxotere(R), the first-line gold standard

Analysis: Cell Genesys soars on GVAX  -  Apr 4, 2007
United Press InternationalIf this holds true in the phase 3 trials, it would be a significant improvement over Taxotere plus prednisone, which has a median survival of 18.9 months,

Dendreon's Provenge: A New Hope For Both Patients and Shareholders  -  Apr 11, 2007
Seeking Alpha,And, if you combine Provenge with Taxotere, which is the only other approved treatment for PC and is one of those brutal chemo treatments, not only is the

Enhancing chemotherapy's efficacy: new agent has synergistic ...  -  Apr 15, 2007
AND,...both in vitro and in vivo when used with current chemotherapy drugs such as taxanes (Taxol and Taxotere) and vinca-alkaloid compounds such as vincristine.

Taxane Use And Dose-Dense Scheduling May Benefit Patients With ...  -  Apr 14, 2007
Medical News Today (press release),Three randomized trials evaluate the addition of paclitaxel (Taxol) to a constant anthracycline-containing regimen; a fourth trial uses docetaxel (Taxotere)

Clarifying the Issues Surrounding Dendreon's Provenge  -  Apr 16, 2007
Seeking Alpha,Although this presentation was indeed a retrospective analysis of 9901/9902a Provenge data, Dr. Petrylak reported that patients who received Taxotere 4 to 6

Cell Genesys Shares Soar on Prostate Cancer Drug Data  -  Apr 3, 2007
Reuters.uk,..."The company has two independent Phase 2 studies, both of which outperformed the current standard of care Taxotere," Canaccord Adams analyst Joseph

Cell Genesys soars on prostate-cancer data  -  Apr 3, 2007
MarketWatchPatients undergoing what's currently the standard chemotherapy regimen for HRPC, which consists primarily of the drugs Taxotere and prednisone,

Fast Track Status Granted for Lung Cancer Treatment  -  Apr 12, 2007
Facts and Comparisons,The FDA has granted fast track status to Cell Therapeutics for Xyotax (biologically enhanced taxotere) for the treatment of poor performance status (PS2)

Dendreon Decision Could Mean FDA Shift  -  Mar 30, 2007
Forbes,The benefit was statistically significant, but the fact that the trial wasn't designed specifically to show it and the small size of the study (Taxotere was

A Radical Attack On Prostate Cancer  -  Mar 28, 2007
Forbes,The Taxotere drug, made by Sanofi-Aventis (nyse: SNY - news - people ), has many unpleasant and dangerous side effects. The data has convinced some who were

FDA advisers OK prostate cancer vaccine  -  Mar 29, 2007
Herald News Daily,The only other prostate cancer drug shown to prolong the lives of patients is Taxotere, also called docetaxel. If ultimately approved, Provenge would become

Health Alert: Fractionated chemo  -  Mar 28, 2007
WIS,Taxotere, commonly used in breast cancer, causes a low blood count. Dr. Willis says, "We see less of that when that drug is fractionated, for example."

Teaching The Body To Fix Itself  -  Apr 21, 2007
BusinessWeek..."These are guys who have one or two years to live, and their only treatment option is Taxotere," a chemotherapy so toxic that many men refuse treatment.

Cell Genesys Provides Final Median Survival Data From Second Phase ...  -  Apr 5, 2007
Drug Newswire (press release),...survival of 18.9 months for metastatic hormone-refractory prostate cancer patients treated with Taxotere(R) (docetaxel) chemotherapy plus prednisone,

Adventrix Pharma Enters Deal With Hyaluron Contract Manufacturing ...  -  Apr 5, 2007
Trading Markets,...pharmacokinetic testing of ANX-514 to compare this product candidate with the approved version of the product, marketed under the brand name Taxotere.

Cell Genesys GVAX data shows survival  -  Apr 3, 2007
BusinessWeek...months for prostate cancer patients given the current standard treatment, Sanofi Aventis SA's Taxotere chemotherapy along with prednisone, the company said.

Drug trial boosts Cell Genesys stock price  -  Apr 4, 2007
Inside Bay Area,The current standard of care, Taxotere, has a median survival rate of about 19 months. Some analysts warned, however, that the sample size for the GVAX

Cell Genesys Up Sharply on Clinical Trial Results  -  Apr 3, 2007
International Business Times,...favorably with the current standard care for such patients, who are treated with Taxotere, or docetaxel, chemotherapy plus prednisone medication.

Fractionated Chemotherapy Can Reduce Side Effects  -  Apr 3, 2007
KDKA,Experts say the more common chemotherapy drugs, like Taxol and Taxotere, can be fractionated, but the technique may not work for others.

Cancer vaccine endorsed  -  Mar 30, 2007
Baltimore Sun,The only other prostate cancer drug shown to prolong the lives of patients is Taxotere, also called docetaxel. A larger, continuing study of Provenge is

US drug agency advisers endorse experimental prostate cancer vaccine  -  Mar 29, 2007
International Herald Tribune,The only other prostate cancer drug shown to prolong the lives of patients is Taxotere, also called docetaxel. A larger study of Provenge is looking

Prostate Vaccine is Endorsed  -  Mar 30, 2007
International News Service,...with those given only dummy treatment. The only other prostate cancer drug shown to prolong the lives of patients is Taxotere, also called docetaxel.

FDA Panel Favors Dendreon's "Provenge" Cancer Vaccine  -  Mar 30, 2007
Seeking Alpha,The only other drug shown to prolong the lives of prostate cancer patients is Sanofi-Aventis's Taxotere. There remains concern that patients on Provenge

FDA panel OKs new prostate cancer vaccine  -  Mar 29, 2007
Long Beach Press-Telegram,...compared to those given only dummy treatment. The only other prostate cancer drug shown to prolong the lives of patients is Taxotere, also called docetaxel.

FDA Mulls Effectiveness  -  Mar 27, 2007
Wall Street Journal (subscription),The only other treatment for advanced prostate cancer that has been shown to improve overall survival is Taxotere, a chemotherapy drug from Sanofi-Aventis.

Genentech Announces First Quarter 2007 Results  -  Apr 12, 2007
PharmaLive.com (press release),As previously announced, Genentech also made a "go" decision for a Phase III study of Omnitarg(TM) (pertuzumab), Herceptin(R) (Trastuzumab) and Taxotere

Genentech Announces First Quarter 2007 Results  -  Apr 11, 2007
Business Wire (press release),As previously announced, Genentech also made a “go� decision for a Phase III study of Omnitarg™ (pertuzumab), Herceptin® (Trastuzumab) and Taxotere versus

Another Cancer Vaccine Promise In Test  -  Apr 9, 2007
The Ledger,The median survival time of patients who take Taxotere after hormonal therapy fails is 18.9 months, according to published research. This can vary, however,

ADVENTRX Grants Manufacturing Contract for ANX-514 (Docetaxel ...  -  Apr 5, 2007
PharmaLive.com (press release),ANX-514 is a novel nano-emulsion formulation of the chemotherapy drug docetaxel, a product marketed under the brand name Taxotere.

ADVENTRX Grants Manufacturing Contract for ANX-514 (Docetaxel ...  -  Apr 5, 2007
PR Newswire (press release),...testing of ANX-514 to compare this product candidate with the approved version of the product, marketed under the brand name Taxotere(R).

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional